NCT00370539Unknown3 期
Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD
适应症
相关药物
试验速览
- 阶段
- 3 期
- 试验地点
- 2
- 主要终点
- Visual acuity
研究概览
简要总结
To compare the efficacy and safety of photodynamic therapy (PDT) combined with intravitreal bevacizumab versus combination of photodynamic therapy , intravitreal bevacizumab and intravitreal triamcinolone for neovascular AMD.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Cases of active neovascular AMD with visual acuity of 20/400- 20/40
排除标准
- •History of glaucoma or ocular hypertension
- •Disciform scar
结局指标
主要结局
Visual acuity
次要结局
- Central macular thickness
- Leakage in fluorescein angiography
- Intraocular pressure
- Anterior chamber reaction
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
2 期
Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMDMacular DegenerationNCT00684853Federal University of São Paulo50
已完成
1 期
Intravitreal Bevacizumab and Low Fluence Photodynamic TherapyMyopiaNCT00802126University of Campania "Luigi Vanvitelli"16
Unknown
3 期
Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMDNeovascular Age-Related Macular DegenerationNCT00370370Shahid Beheshti University of Medical Sciences
撤回
2 期
Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic RetinopathyDiabetic RetinopathyNCT00347698Asociación para Evitar la Ceguera en México
已完成
不适用
Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular EdemaDiabetic Macular EdemaNCT02310295University of Sao Paulo45